I Toprak1, V Kucukatay2, C Yildirim3, E Kilic-Toprak2, O Kilic-Erkek2. 1. Department of Ophthalmology, Servergazi State Hospital, Denizli, Turkey. 2. Department of Physiology, Faculty of Medicine, Pamukkale University, Denizli, Turkey. 3. 1] Department of Ophthalmology, Faculty of Medicine, Pamukkale University, Denizli, Turkey [2] Private Ege Akademi Eye Hospital, Denizli, Turkey.
Abstract
PURPOSE: To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. METHODS: Twenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated. RESULTS: The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497). CONCLUSIONS: The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus.
PURPOSE: To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. METHODS: Twenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated. RESULTS: The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497). CONCLUSIONS: The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus.
Authors: Shari R Atilano; Pinar Coskun; Marilyn Chwa; Nicole Jordan; Vinitha Reddy; Khoi Le; Douglas C Wallace; M Cristina Kenney Journal: Invest Ophthalmol Vis Sci Date: 2005-04 Impact factor: 4.799
Authors: Nitin Udar; Shari R Atilano; Donald J Brown; Bret Holguin; Kent Small; Anthony B Nesburn; M Cristina Kenney Journal: Invest Ophthalmol Vis Sci Date: 2006-08 Impact factor: 4.799
Authors: Hui Qi; Shrestha Priyadarsini; Sarah E Nicholas; Akhee Sarker-Nag; Jeremy Allegood; Charles E Chalfant; Nawajes A Mandal; Dimitrios Karamichos Journal: J Lipid Res Date: 2017-02-10 Impact factor: 5.922
Authors: L Rico-Del-Viejo; M Garcia-Montero; J L Hernández-Verdejo; S García-Lázaro; F J Gómez-Sanz; A Lorente-Velázquez Journal: J Ophthalmol Date: 2017-12-21 Impact factor: 1.909